학술논문
4. Post-marketing safety study to evaluate the occurrence of aseptic meningitis syndrome (AMS) in an adult population (⩾18 years) treated with doses of ⩾1 g/kg INTRAGAM10®
Document Type
Abstract
Author
Source
In Clinical Neurophysiology March 2020 131(3):e2-e2
Subject
Language
ISSN
1388-2457